Maria Dauvermann, Postdoctoral Associate
Enrollment: Limited: First come, first served (no advance sign-up)
Limited to 15 participants
Attendance: Participants must attend all sessions
Prereq: None
It has been estimated that 18.5% of adults in the U.S. had a psychiatric disorder in 2013. The treatment success rates with traditional pharmacology among every psychiatric disorder are very low. This goes hand-in-hand with the limitations of currently available diagnostic and prognostic tools.
We know that the brain plays a major role in the development of these disorders. Therefore, technologies for potential diagnosis and treatment options have been developed that aim to change the function of the brain. These new technologies for diagnosis and invention approaches are in development but require thorough translational research before they can be safely used in patients.
The aim of the course is to teach about technologies and intervention approaches that move beyond pharmacology as the sole treatment option. Over the course of four sessions, you will learn how brain scientists from different disciplines (biologists, chemists, physicists, psychologists, informaticians, engineers) invent and develop techniques in multiple translational steps as diagnosis and treatment options for patients. You will design and present your own translational study at the end of the course.
Session 1: Currently available techniques and treatment options
Session 2: Promising technologies for diagnosis and treatment options in humans, monkeys and rodents
Session 3: Practical translational research steps across species
Session 4: Design, presentation and discussion of translational studies
Sponsor(s): Brain and Cognitive Sciences
Contact: Maria Dauvermann, 46-2171, 617-324-3599, mariad@mit.edu
| Jan/07 | Thu | 01:00PM-03:00PM | 46-4062 |
| Jan/08 | Fri | 01:00PM-03:00PM | 46-4062 |
| Jan/14 | Thu | 01:00PM-03:00PM | 46-4062 |
| Jan/15 | Fri | 01:00PM-03:00PM | 46-4062 |
Maria Dauvermann - Postdoctoral Associate